Expression of activated type I receptor tyrosine kinases in early breast cancer

Breast Cancer Research and Treatment
Melanie SpearsJohn M S Bartlett

Abstract

Overexpression of EGFR, HER2 and HER3 are known to be associated with poor outcome in breast cancer. Few studies have examined the clinical impact of activation of these proteins. In the present study, we evaluated EGFR, HER2 and HER3 and the activated (phosphorylated) forms of these proteins in patients with early breast cancer. EGFR, HER2, HER3, pEGFR, pHER2 and pHER3 expression was determined by immunohistochemical analysis of tissue microarrays constructed from tumours within the Edinburgh Breast Conservation Series (BCS). The BCS represents a fully-documented consecutive cohort of 1,812 patients treated by breast conservation surgery in a single institution. Our results demonstrate overexpression of HER2 and pHER2 to be associated with a significant reduction in overall survival (OS) (HR: 1.66, 95 % CI 1.22-2.26, p = 0.001 and HR: 1.57, 95 % CI 1.22-2.03, p = 0.001, respectively) and distant relapse-free survival (DRFS) (HR: 1.63, 95 % CI 1.23-2.18, p = 0.001 and HR: 1.55, 95 % CI 1.23-1.97, p = 0.0002, respectively). Paradoxically, expression of pEGFR was associated with a significantly improved OS (HR: 0.67 95 % CI 0.50-0.91, p = 0.01) and DRFS (HR: 0.73, 95 % CI 0.56-0.96, p = 0.025). Expression of activated EGFR/HER2 p...Continue Reading

References

Apr 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·L N KlapperY Yarden
Nov 1, 2000·Cell·J Schlessinger
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y Yarden
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett
Oct 19, 2004·Seminars in Oncology·Yosef YardenDavid Miles
Feb 3, 2005·The Journal of Pathology·John M S BartlettJoanne Edwards
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael P DiGiovannaAnn D Thor
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sian ToveyJohn M S Bartlett
Jul 27, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Aug 10, 2005·The Journal of Pathology·Tove KirkegaardJohn M S Bartlett
Aug 18, 2005·British Journal of Cancer·L M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Sep 29, 2005·PLoS Medicine·Heidi GreulichMatthew Meyerson
Apr 12, 2006·Breast Cancer Research : BCR·Sian M ToveyJohn M S Bartlett
Aug 26, 2006·Breast Cancer Research and Treatment·Lisa M McShaneUNKNOWN Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics
Sep 28, 2006·Breast Cancer Research and Treatment·Elizabeth CanningsJohn M S Bartlett
Aug 1, 2007·BMC Genomics·Katherine A HoadleyCharles M Perou
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yago NietoSamia Nawaz
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen
Apr 3, 2008·Journal of Clinical Pathology·R A WalkerS E Pinder
Jun 5, 2008·Breast Cancer Research : BCR·Christina MagkouIoanna Giannopoulou
Sep 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M S BartlettChris J Twelves
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian R Leyland-JonesUNKNOWN Children's Oncology Group
Mar 11, 2011·Breast Cancer Research and Treatment·Melanie SpearsJohn M S Bartlett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.